report cover

Global Depression Screening Market Research Report - Forecast to 2028

  • 22 February 2022
  • Life Sciences
  • 101 Pages
  • Report code : 24WT-6903007

Depression Screening Market

Table of Contents

1 Report Prologue 12
2 Market Introduction 16
2.1 Scope of Study 16
2.2 Research Objective 16
2.3 Assumptions & Limitations 16
2.3.1 Assumptions 16
2.3.2 Limitations 16
3 Research Methodology 17
3.1 Primary Research Methodology 18
3.2 Secondary Research Methodology 19
3.3 Market Share Analysis 20
3.4 Trade Analysis 20
3.5 Market Pricing Approach 20
4 Market Dynamics 21
4.1 Introduction 21
4.2 Drivers 22
4.2.1 Emergence of digital health technologies in mental health
(Impact weightage-45%) 22
4.2.2 Growing prevalence of mental disorders around the globe
(Impact weightage-30%) 23
4.2.3 New focus areas in the care continuum are prevention and recovery
(Impact weightage-25%) 24
4.3 Restraints 25
4.3.1 Low public awareness of mental disorders and treatments in emerging nations (Impact weightage-55%) 25
4.3.2 Cultural Stigma preventing the market growth (Impact weightage-45%) 26
5 Market Factor Analysis 27
5.1 Porter?s Five Forces Model 27
5.1.1 Bargaining Power of Suppliers 28
5.1.2 Bargaining Power of Buyers 28
5.1.3 Threat of New Entrants 28
5.1.4 Threat of Substitutes 28
5.1.5 Intensity of Rivalry 28
5.2 Value Chain Analysis 29
?
6 Global Depression Screening Market, By Disease Type 30
6.1 Introduction 30
6.2 Anxiety 32
6.3 Mood Disorders 32
6.4 Depression 33
6.5 Bipolar Disorders 33
6.6 Psychotic Disorders 34
6.7 Eating Disorders 34
7 Global Depression Screening Market, By Diagnosis 35
7.1 Introduction 35
7.2 Psychological Test 36
7.3 Lab Tests 37
7.4 Depression Screening Tests 37
8 Global Depression Screening Market, By Treatment 38
8.1 Introduction 38
8.2 Medication 40
8.3 Brain-Stimulation Treatments 40
8.4 Substance Abuse Treatment 41
9 Global Depression Screening Market, By End User 42
9.1 Introduction 42
9.2 Hospitals & Clinics 43
9.3 Medical Research Centers 43
9.4 Academic Institutes 44
10 Global Depression Screening Market, By Region 45
10.1 Introduction 45
10.2 Americas 46
10.2.1 U.S. 49
10.2.2 Canada 51
10.2.3 South America 53
10.3 Europe 55
10.3.1 Germany 58
10.3.2 France 60
10.3.3 UK 62
10.3.4 Italy 64
10.3.5 Spain 66
10.3.6 Rest of Western Europe 68
10.3.7 Eastern Europe 70
?
10.4 Asia Pacific 72
10.4.1 Japan 75
10.4.2 China 77
10.4.3 India 79
10.4.4 Australia 81
10.4.5 Republic of Korea 83
10.4.6 Rest of Asia Pacific 85
10.5 Middle East & Africa 87
10.5.1 Middle East 90
10.5.2 Africa 92
11 Company Share Analysis 94
12 Company Profiles: Top 7 Players 95
12.1 Allergan 95
12.1.1 Company Overview 95
12.1.2 Financials 95
12.1.3 Products 95
12.1.4 Strategy 95
12.1.5 Key Developments 95
12.2 Eli Lilly 96
12.2.1 Company Overview 96
12.2.2 Financials 96
12.2.3 Products 96
12.2.4 Strategy 96
12.2.5 Key Developments 96
12.3 Novartis AG. 97
12.3.1 Company Overview 97
12.3.2 Financials 97
12.3.3 Products 97
12.3.4 Strategy 97
12.3.5 Key Developments 97
12.4 Alkermes 98
12.4.1 Company Overview 98
12.4.2 Financials 98
12.4.3 Products 98
12.4.4 Strategy 98
12.4.5 Key Developments 98
12.5 Bristol-Myers Squibb Company 99
12.5.1 Company Overview 99
12.5.2 Financials 99
12.5.3 Products 99
12.5.4 Strategy 99
12.5.5 Key Developments 99
12.6 Pfizer 100
12.6.1 Company Overview 100
12.6.2 Financials 100
12.6.3 Products 100
12.6.4 Strategy 100
12.6.5 Key Developments 100

Ask Our Expert

Leave This Empty:

*Required Information
TABLE 1 PRIMARY INTERVIEWS 18
TABLE 2 GLOBAL DEPRESSION SCREENING MARKET, BY DISEASE TYPE, 2014-2028 (USD MILLION) 31
TABLE 3 GLOBAL DEPRESSION SCREENING MARKET FOR ANXIETY, BY REGION, 2014-2028 (USD MILLION) 32
TABLE 4 GLOBAL DEPRESSION SCREENING MARKET FOR MOOD DISORDERS, BY REGION,
2014-2028 (USD MILLION) 32
TABLE 5 GLOBAL DEPRESSION SCREENING MARKET FOR DEPRESSION, BY REGION, 2014-2028 (USD MILLION) 33
TABLE 6 GLOBAL DEPRESSION SCREENING MARKET FOR BIPOLAR DISORDERS, BY REGION,
2014-2028 (USD MILLION) 33
TABLE 7 GLOBAL DEPRESSION SCREENING MARKET FOR PSYCHOTIC DISORDERS, BY REGION,
2014-2028 (USD MILLION) 34
TABLE 8 GLOBAL DEPRESSION SCREENING MARKET FOR EATING DISORDERS, BY REGION,
2014-2028 (USD MILLION) 34
TABLE 9 GLOBAL DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2014-2028 (USD MILLION) 35
TABLE 10 GLOBAL DEPRESSION SCREENING MARKET FOR PSYCHOLOGICAL TEST, BY REGION,
2014-2028 (USD MILLION) 36
TABLE 11 GLOBAL DEPRESSION SCREENING MARKET FOR LAB TESTS, BY REGION, 2014-2028 (USD MILLION) 37
TABLE 12 GLOBAL DEPRESSION SCREENING MARKET FOR DEPRESSION SCREENING TESTS, BY REGION,
2014-2028 (USD MILLION) 37
TABLE 13 GLOBAL DEPRESSION SCREENING MARKET, BY TREATMENT, 2014-2028 (USD MILLION) 39
TABLE 14 GLOBAL DEPRESSION SCREENING MARKET FOR MEDICATION, BY REGION, 2014-2028 (USD MILLION) 40
TABLE 15 GLOBAL DEPRESSION SCREENING MARKET FOR BRAIN-STIMULATION TREATMENTS, BY REGION,
2014-2028 (USD MILLION) 40
TABLE 16 GLOBAL DEPRESSION SCREENING MARKET FOR SUBSTANCE ABUSE TREATMENT, BY REGION,
2014-2028 (USD MILLION) 41
TABLE 17 GLOBAL DEPRESSION SCREENING MARKET, BY END USER, 2014-2028 (USD MILLION) 42
TABLE 18 GLOBAL DEPRESSION SCREENING MARKET FOR HOSPITALS & CLINICS, BY REGION,
2014-2028 (USD MILLION) 43
TABLE 19 GLOBAL DEPRESSION SCREENING MARKET FOR MEDICAL RESEARCH CENTERS, BY REGION,
2014-2028 (USD MILLION) 43
TABLE 20 GLOBAL DEPRESSION SCREENING MARKET FOR ACADEMIC INSTITUTES, BY REGION,
2014-2028 (USD MILLION) 44
TABLE 21 GLOBAL DEPRESSION SCREENING MARKET, BY REGION, 2014-2028 (USD MILLION) 45
TABLE 22 AMERICAS DEPRESSION SCREENING MARKET, BY COUNTRY, 2014-2028 (USD MILLION) 46
TABLE 23 AMERICAS DEPRESSION SCREENING MARKET, BY DISEASE TYPE, 2014-2028 (USD MILLION) 47
TABLE 24 AMERICAS DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2014-2028 (USD MILLION) 47
TABLE 25 AMERICAS DEPRESSION SCREENING MARKET, BY TREATMENT, 2014-2028 (USD MILLION) 48
TABLE 26 AMERICAS DEPRESSION SCREENING MARKET, BY END USER, 2014-2028 (USD MILLION) 48
TABLE 27 U.S. DEPRESSION SCREENING MARKET, BY DISEASE TYPE, 2014-2028 (USD MILLION) 49
TABLE 28 U.S. DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2014-2028 (USD MILLION) 49
TABLE 29 U.S. DEPRESSION SCREENING MARKET, BY TREATMENT, 2014-2028 (USD MILLION) 50
TABLE 30 U.S. DEPRESSION SCREENING MARKET, BY END USER, 2014-2028 (USD MILLION) 50
TABLE 31 CANADA DEPRESSION SCREENING MARKET, BY DISEASE TYPE, 2014-2028 (USD MILLION) 51
TABLE 32 CANADA DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2014-2028 (USD MILLION) 51
TABLE 33 CANADA DEPRESSION SCREENING MARKET, BY TREATMENT, 2014-2028 (USD MILLION) 52
TABLE 34 CANADA DEPRESSION SCREENING MARKET, BY END USER, 2014-2028 (USD MILLION) 52
TABLE 35 SOUTH AMERICA DEPRESSION SCREENING MARKET, BY DISEASE TYPE, 2014-2028 (USD MILLION) 53
TABLE 36 SOUTH AMERICA DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2014-2028 (USD MILLION) 53
TABLE 37 SOUTH AMERICA DEPRESSION SCREENING MARKET, BY TREATMENT, 2014-2028 (USD MILLION) 54
TABLE 38 SOUTH AMERICA DEPRESSION SCREENING MARKET, BY END USER, 2014-2028 (USD MILLION) 54
TABLE 39 EUROPE DEPRESSION SCREENING MARKET, BY COUNTRY, 2014-2028 (USD MILLION) 55
TABLE 40 EUROPE DEPRESSION SCREENING MARKET, BY DISEASE TYPE, 2014-2028 (USD MILLION) 56
TABLE 41 EUROPE DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2014-2028 (USD MILLION) 56
TABLE 42 EUROPE DEPRESSION SCREENING MARKET, BY TREATMENT, 2014-2028 (USD MILLION) 57
TABLE 43 EUROPE DEPRESSION SCREENING MARKET, BY END USER, 2014-2028 (USD MILLION) 57
TABLE 44 GERMANY DEPRESSION SCREENING MARKET, BY DISEASE TYPE, 2014-2028 (USD MILLION) 58
TABLE 45 GERMANY DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2014-2028 (USD MILLION) 58
TABLE 46 GERMANY DEPRESSION SCREENING MARKET, BY TREATMENT, 2014-2028 (USD MILLION) 59
TABLE 47 GERMANY DEPRESSION SCREENING MARKET, BY END USER, 2014-2028 (USD MILLION) 59
TABLE 48 FRANCE DEPRESSION SCREENING MARKET, BY DISEASE TYPE, 2014-2028 (USD MILLION) 60
TABLE 49 FRANCE DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2014-2028 (USD MILLION) 60
TABLE 50 FRANCE DEPRESSION SCREENING MARKET, BY TREATMENT, 2014-2028 (USD MILLION) 61
TABLE 51 FRANCE DEPRESSION SCREENING MARKET, BY END USER, 2014-2028 (USD MILLION) 61
TABLE 52 UK DEPRESSION SCREENING MARKET, BY DISEASE TYPE, 2014-2028 (USD MILLION) 62
TABLE 53 UK DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2014-2028 (USD MILLION) 62
TABLE 54 UK DEPRESSION SCREENING MARKET, BY TREATMENT, 2014-2028 (USD MILLION) 63
TABLE 55 UK DEPRESSION SCREENING MARKET, BY END USER, 2014-2028 (USD MILLION) 63
TABLE 56 ITALY DEPRESSION SCREENING MARKET, BY DISEASE TYPE, 2014-2028 (USD MILLION) 64
TABLE 57 ITALY DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2014-2028 (USD MILLION) 64
TABLE 58 ITALY DEPRESSION SCREENING MARKET, BY TREATMENT, 2014-2028 (USD MILLION) 65
TABLE 59 ITALY DEPRESSION SCREENING MARKET, BY END USER, 2014-2028 (USD MILLION) 65
TABLE 60 SPAIN DEPRESSION SCREENING MARKET, BY DISEASE TYPE, 2014-2028 (USD MILLION) 66
TABLE 61 SPAIN DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2014-2028 (USD MILLION) 66
TABLE 62 SPAIN DEPRESSION SCREENING MARKET, BY TREATMENT, 2014-2028 (USD MILLION) 67
TABLE 63 SPAIN DEPRESSION SCREENING MARKET, BY END USER, 2014-2028 (USD MILLION) 67
TABLE 64 REST OF WESTERN EUROPE DEPRESSION SCREENING MARKET, BY DISEASE TYPE,
2014-2028 (USD MILLION) 68
TABLE 65 REST OF WESTERN EUROPE DEPRESSION SCREENING MARKET, BY DIAGNOSIS,
2014-2028 (USD MILLION) 68
TABLE 66 REST OF WESTERN EUROPE DEPRESSION SCREENING MARKET, BY TREATMENT,
2014-2028 (USD MILLION) 69
TABLE 67 REST OF WESTERN EUROPE DEPRESSION SCREENING MARKET, BY END USER,
2014-2028 (USD MILLION) 69
TABLE 68 EASTERN EUROPE DEPRESSION SCREENING MARKET, BY DISEASE TYPE, 2014-2028 (USD MILLION) 70
TABLE 69 EASTERN EUROPE DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2014-2028 (USD MILLION) 70
TABLE 70 EASTERN EUROPE DEPRESSION SCREENING MARKET, BY TREATMENT, 2014-2028 (USD MILLION) 71
TABLE 71 EASTERN EUROPE DEPRESSION SCREENING MARKET, BY END USER, 2014-2028 (USD MILLION) 71
TABLE 72 ASIA PACIFIC DEPRESSION SCREENING MARKET, BY COUNTRY, 2014-2028 (USD MILLION) 72
TABLE 73 ASIA PACIFIC DEPRESSION SCREENING MARKET, BY DISEASE TYPE, 2014-2028 (USD MILLION) 73
TABLE 74 ASIA PACIFIC DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2014-2028 (USD MILLION) 73
TABLE 75 ASIA PACIFIC DEPRESSION SCREENING MARKET, BY TREATMENT, 2014-2028 (USD MILLION) 74
TABLE 76 ASIA PACIFIC DEPRESSION SCREENING MARKET, BY END USER, 2014-2028 (USD MILLION) 74
TABLE 77 JAPAN DEPRESSION SCREENING MARKET, BY DISEASE TYPE, 2014-2028 (USD MILLION) 75
TABLE 78 JAPAN DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2014-2028 (USD MILLION) 75
TABLE 79 JAPAN DEPRESSION SCREENING MARKET, BY TREATMENT, 2014-2028 (USD MILLION) 76
TABLE 80 JAPAN DEPRESSION SCREENING MARKET, BY END USER, 2014-2028 (USD MILLION) 76
TABLE 81 CHINA DEPRESSION SCREENING MARKET, BY DISEASE TYPE, 2014-2028 (USD MILLION) 77
TABLE 82 CHINA DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2014-2028 (USD MILLION) 77
TABLE 83 CHINA DEPRESSION SCREENING MARKET, BY TREATMENT, 2014-2028 (USD MILLION) 78
TABLE 84 CHINA DEPRESSION SCREENING MARKET, BY END USER, 2014-2028 (USD MILLION) 78
TABLE 85 INDIA DEPRESSION SCREENING MARKET, BY DISEASE TYPE, 2014-2028 (USD MILLION) 79
TABLE 86 INDIA DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2014-2028 (USD MILLION) 79
TABLE 87 INDIA DEPRESSION SCREENING MARKET, BY TREATMENT, 2014-2028 (USD MILLION) 80
TABLE 88 INDIA DEPRESSION SCREENING MARKET, BY END USER, 2014-2028 (USD MILLION) 80
TABLE 89 AUSTRALIA DEPRESSION SCREENING MARKET, BY DISEASE TYPE, 2014-2028 (USD MILLION) 81
TABLE 90 AUSTRALIA DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2014-2028 (USD MILLION) 81
TABLE 91 AUSTRALIA DEPRESSION SCREENING MARKET, BY TREATMENT, 2014-2028 (USD MILLION) 82
TABLE 92 AUSTRALIA DEPRESSION SCREENING MARKET, BY END USER, 2014-2028 (USD MILLION) 82
TABLE 93 REPUBLIC OF KOREA DEPRESSION SCREENING MARKET, BY DISEASE TYPE, 2014-2028 (USD MILLION) 83
TABLE 94 REPUBLIC OF KOREA DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2014-2028 (USD MILLION) 83
TABLE 95 REPUBLIC OF KOREA DEPRESSION SCREENING MARKET, BY TREATMENT, 2014-2028 (USD MILLION) 84
TABLE 96 REPUBLIC OF KOREA DEPRESSION SCREENING MARKET, BY END USER, 2014-2028 (USD MILLION) 84
TABLE 97 REST OF ASIA PACIFIC DEPRESSION SCREENING MARKET, BY DISEASE TYPE, 2014-2028 (USD MILLION) 85
TABLE 98 REST OF ASIA PACIFIC DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2014-2028 (USD MILLION) 85
TABLE 99 REST OF ASIA PACIFIC DEPRESSION SCREENING MARKET, BY TREATMENT, 2014-2028 (USD MILLION) 86
TABLE 100 REST OF ASIA PACIFIC DEPRESSION SCREENING MARKET, BY END USER, 2014-2028 (USD MILLION) 86
TABLE 101 MIDDLE EAST & AFRICA DEPRESSION SCREENING MARKET, BY COUNTRY, 2014-2028 (USD MILLION) 87
TABLE 102 MIDDLE EAST & AFRICA DEPRESSION SCREENING MARKET, BY DISEASE TYPE, 2014-2028 (USD MILLION) 88
TABLE 103 MIDDLE EAST & AFRICA DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2014-2028 (USD MILLION) 88
TABLE 104 MIDDLE EAST & AFRICA DEPRESSION SCREENING MARKET, BY TREATMENT, 2014-2028 (USD MILLION) 89
TABLE 105 MIDDLE EAST & AFRICA DEPRESSION SCREENING MARKET, BY END USER, 2014-2028 (USD MILLION) 89
TABLE 106 MIDDLE EAST DEPRESSION SCREENING MARKET, BY DISEASE TYPE, 2014-2028 (USD MILLION) 90
TABLE 107 MIDDLE EAST DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2014-2028 (USD MILLION) 90
TABLE 108 MIDDLE EAST DEPRESSION SCREENING MARKET, BY TREATMENT, 2014-2028 (USD MILLION) 91
TABLE 109 MIDDLE EAST DEPRESSION SCREENING MARKET, BY END USER, 2014-2028 (USD MILLION) 91
TABLE 110 AFRICA DEPRESSION SCREENING MARKET, BY DISEASE TYPE, 2014-2028 (USD MILLION) 92
TABLE 111 AFRICA DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2014-2028 (USD MILLION) 92
TABLE 112 AFRICA DEPRESSION SCREENING MARKET, BY TREATMENT, 2014-2028 (USD MILLION) 93
TABLE 113 AFRICA DEPRESSION SCREENING MARKET, BY END USER, 2014-2028 (USD MILLION) 93

FIGURE 1 GLOBAL DEPRESSION SCREENING MARKET SHARE, BY DISEASE TYPE 2021 (%) 13
FIGURE 2 GLOBAL DEPRESSION SCREENING MARKET SHARE, BY DIAGNOSIS, 2021 (%) 13
FIGURE 3 GLOBAL DEPRESSION SCREENING MARKET SHARE, BY TREATMENT, 2021 (%) 14
FIGURE 4 GLOBAL DEPRESSION SCREENING MARKET, BY REGION, 2021 (%) 15
FIGURE 5 RESEARCH METHODOLOGY 17
FIGURE 6 PORTERS FIVE FORCES MODEL 27
FIGURE 7 VALUE CHAIN: DEPRESSION SCREENING MARKET 29
FIGURE 8 GLOBAL DEPRESSION SCREENING MARKET, BY DISEASE TYPE, 2021 & 2028 (USD MILLION) 31
FIGURE 9 GLOBAL DEPRESSION SCREENING MARKET, BY DIAGNOSIS, 2021 & 2028 (USD MILLION) 36
FIGURE 10 GLOBAL DEPRESSION SCREENING MARKET, BY TREATMENT, 2021 & 2028 (USD MILLION) 39
FIGURE 11 GLOBAL DEPRESSION SCREENING MARKET, BY END USER, 2021 & 2028 (USD MILLION) 42
FIGURE 12 AMERICAS DEPRESSION SCREENING MARKET, BY COUNTRY, 2021 (%) 46
FIGURE 13 EUROPE DEPRESSION SCREENING MARKET, BY COUNTRY, 2021 (%) 55
FIGURE 14 ASIA PACIFIC DEPRESSION SCREENING MARKET, BY COUNTRY, 2021 (%) 72
FIGURE 15 MIDDLE EAST & AFRICA DEPRESSION SCREENING MARKET, BY COUNTRY, 2021 (%) 87
FIGURE 16 GLOBAL DERESSION SCREENING MARKET: COMPANY SHARE ANALYSIS 94
Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Depression Screening Market

Leave This Empty: